Thrombospondin-1-Deficient Mice Exhibit Increased Vascular Density during Retinal Vascular Development and Are Less Sensitive to Hyperoxia-Mediated Vessel Obliteration

Developmental Dynamics

Volumn 228, Issue 4, 2003, Pages 630-642

  Wang, Shoujian ^a   Wu, Zhifeng ^a,c   Sorenson, Christine M ^a   Lawler, Jack ^b   Sheibani, Nader ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WUXI PEOPLE'S HOSPITAL   (China)

Author keywords

Angiogenesis; Apoptosis; Retinal pericytes; Retinal vasculature; Retinopathy of prematurity

Indexed keywords

THROMBOSPONDIN 1;

ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ENDOTHELIUM CELL; HYPEROXIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA;

ANIMALS; ANOXIA; APOPTOSIS; BLOTTING, NORTHERN; COLLAGEN; ENDOTHELIUM, VASCULAR; IN SITU NICK-END LABELING; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; PHENOTYPE; RETINAL DISEASES; RETINAL VESSELS; THROMBOSPONDIN 1; TIME FACTORS;

EID: 0344305662     PISSN: 10588388     EISSN: None     Source Type: Journal    
DOI: 10.1002/dvdy.10412     Document Type: Article

References (37)

1. Adams JC. 2001. Thrombospondins: multifunctional regulators of cell Interactions. Annu Rev Cell Dev Biol 17:25-51.
2. Agardh C, Agardh E, Hultberg B, Ahren B. 2000. Long-standing hyperglycemia in C57BL/6J mice does not affect retinal glutathione levels or endothelial/pericyte ratio in retinal capillaries. J Diabetes Complications 14:146-153.
3. Alon T, Hemo L, Itlin A, Pe'er J, Stone J, Keshet E. 1995. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
4. Beck L, D'Amore PA. 1997. Vascular development: cellular and molecular regulation. FASEB J 11:365-373.
5. Benjamin LE, Hemo I, Keshet E. 1998. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598.
6. Blank JC, Johnson LV. 1983. Selective lectin binding of the developing mouse retina. J Comp Neurol 221:31-41.
7. Bornstein P. 2001. Thrombospondins as matricellular modulators of cell function. J Clin Invest 107:929-934
8. Connolly SE, Hores TA, Smith LEH, D'Amore PA. 1988. Characterization of vascular development in the mouse retina. Microvasc Res 36:275-290.
9. Cuthbertson RA, Mandel TE. 1986. Anatomy of the mouse retina: endothelial cell-pericyte ratio and capillary distribution. Invest Ophthalmol Vis Sci 27: 1659-1664.
10. Darland DC, D'Amore PA. 1999. Blood vessel maturation: vascular development comes of age. J Clin Invest 103; 157-158.
11. Fruttiger M. 2002. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43:522-527.
12. Hughes S, Yamg H, Chan-Ling T. 2000. Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci 41: 1217-1228.
13. Ito M, Yoshioka M. 1999. Regression of the hyaloid vessels and papillary membrane of the mouse. Anat Embryol (Berl) 200:403-411.
14. Jiang B, Bezhadian MA, Caldwell RB. 1995. Astrocytes modulate retinal vasculogenesis: effects on endothelial cell differentiation. Glia 15:1-10.
15. Jimenez B, Volpert OV, Crawford SE, Febbralo M, Silverstein RL, Bouck N. 2000. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41-48.
16. Jimenez B, Volpert OV, Reiher F, Chang L, Munoz A, Karin M, Bouck N. 2001. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene 20: 3443-3448.
17. Keshet E. 2001. More weapons in the retinal ischemic retinopathy. J Clin Invest 107:945-946.
18. Lawler J. 2000. The functions of thrombospondin-1 and -2. Curr Opin Cell Biol 12:634-640.
19. Lawler J, Sunday M, Thibert V, Duquette M, George EL, Rayburn H, Hynes RO. 1998. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101:982-992.
20. Nor JE, Christensen J, Mooney DJ, Polverini PJ. 1999. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384.
21. Nor JE, Mitra RS, Sutorik MM, Mooney DJ, Castle VP, Polverini PJ. 2000. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway. J Vasc Res 37:209-218.
22. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. 2001. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and acceleratestumor growth, Cancer Res 61:2183-2188.
23. Pierce EA, Avery RL, Foley ED, Aielo LP, Smith LE. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 92:905-909.
24. Pierce EA, Foley ED, Smith LEH. 1996. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219-1228.
25. Reed MJ, Iruela-Arispe L, O'Brien ER, Truong T, LaBell T, Bornstein P, Sage EH. 1995. Expression of thrombospondins by endothelial cells, injury is correlated with TSP-1. Am J Pathol 147:1068-1080.
26. Schlingemann RO, van Hinsbergh VWM. 1997. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 81:501-512.
27. Shaflee A, Penn JS, Krutzsch HC, Inman JK, Roberts DD, Blake DA. 2000. Inhibition of retinal angiogenesis by peptides derived from thrombospondin-1. Invest Ophthalmol Vis Sci 41:2378-2388.
28. Shelbani N, Frazier WA. 1995. Thrombospondin-1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci U S A 92: 6788-6792.
29. Sheibani N, Frazier WA. 1999. Thrombospondin-1, PECAM-1, and regulation of angiogenesis. Histol Histopathol 14: 285-294.
30. Sheibani N, Newman PJ, Frazier WA. 1997. Thrombospondin-1, a natural inhibitor of angiogenesis, regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol Biol Cell 8:1329-1341.
31. Sheibani N, Sorenson CM, Cornelius LA, Frazier WA. 2000. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia. Biochem Biophys Res Commun 267:257-261.
32. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
33. Stellmach V, Crawford SE, Zhou W, Bouck N. 2001. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98:2593-2597.
34. Su X, Sorenson CM, Sheibani N. 2003. Isolation and characterization of murine retinal endothelial cells. Mol Vis 9:171-178.
35. Suzuma K, Takagi H, Otani A, Oh H, Honda Y. 1999. Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. Am J Pathol 154: 343-354.
36. Volpert OV. 2000. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance. Cancer Metastasis Rev 19:87-92.
37. Yamada H, Yamada E, Hackett S, Ozaki H, Okamoto N, Campochiaro P. 1999. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina. J Cell Physiol 179:149-156.